bortezomib,lenalidomide,dexamethasone
bms
['mmsm', 'determination']
interesting sub group data suggesting lower benefit of asct for the black ethnic group in the determination trial of rvd-rvd- r vs rvd-asct-r for myeloma. need to understand better if this is a real difference or due to small groups. #eha2022 #mmsm. 
Haematologist @uclh, associate professor @ucl. Chair NCRI Myeloma Group (UK Myeloma Research Alliance). All views are my own.